STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLS
  4. [Form 4] CELESTICA INC Insider Trading Activity

Celestica Inc (CLS) director receives 317 D‑RSUs, lifting holdings to 1,127

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KOELLNER LAURETTE T reported acquisition or exercise transactions in this Form 4 filing.

Celestica Inc director Laurette T. Koellner received an equity award of 317 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU is a contingent right to receive one common share upon settlement, subject to any deferral election, or, at Celestica’s election, an equivalent value in cash. These 317 D‑RSUs vest on May 20, 2027, bringing Koellner’s directly held D‑RSU balance to 1,127 units following the grant.

Positive

  • None.

Negative

  • None.
Insider KOELLNER LAURETTE T
Role Director
Type Security Shares Price Value
Grant/Award Director Restricted Share Units F1, F2 317 $0.00 $0.00
Holdings After Transaction: Director Restricted Share Units — 1,127 shares (Direct)
Footnotes (2)
  1. F1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.
  2. F2. On August 11, 2026, the reporting person was granted 317 D-RSUs, which vest on May 20, 2027.
D-RSUs granted 317 Director Restricted Share Units Grant to Laurette T. Koellner on August 11, 2026
Holdings after transaction 1,127 Director Restricted Share Units Direct D-RSU balance following the reported grant
Vesting date May 20, 2027 Vesting date for the 317 newly granted D-RSUs
Conversion ratio 1 D-RSU : 1 common share Each D-RSU represents a contingent right to receive one common share or cash equivalent
Director Restricted Share Units financial
"Each director restricted share unit ("D-RSU") represents a contingent right"
contingent right financial
"represents a contingent right to receive one common share upon settlement"
deferral election financial
"upon settlement, subject to the reporting person's deferral election"

FAQ

What did Celestica (CLS) director Laurette T. Koellner receive in this Form 4?
Laurette T. Koellner was granted 317 Director Restricted Share Units on August 11, 2026. These units are a form of equity-based compensation that convert into Celestica common shares or cash when settled, depending on company and deferral elections.

How many Director Restricted Share Units does the Celestica (CLS) director hold after the grant?
After the reported transaction, Laurette T. Koellner holds 1,127 Director Restricted Share Units directly. This total includes the new 317-unit grant reported, plus previously awarded D‑RSUs that remain outstanding in her director equity account.

When do the newly granted D-RSUs to the Celestica (CLS) director vest?
The 317 D‑RSUs granted to Laurette T. Koellner on August 11, 2026 vest on May 20, 2027. Vesting means the units become earned, after which they can later be settled in common shares or cash under plan terms.

What does each Director Restricted Share Unit represent for Celestica (CLS)?
Each D‑RSU represents a contingent right to one Celestica common share upon settlement or, at Celestica’s election, an equivalent value in cash. Settlement timing can be affected by the director’s deferral election under the plan.

Was the Celestica (CLS) director’s Form 4 transaction under a Rule 10b5-1 plan?
The filing’s Rule 10b5‑1 checkbox is not marked as a plan transaction. The reported activity is a compensation-related grant, not an open-market trade executed under a pre-arranged Rule 10b5‑1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KOELLNER LAURETTE T
(Last)(First)(Middle)
5140 YONGE STREET
SUITE 1900
(Street)
TORONTOM2N 6L7
(City)(State)(Zip)
ONTARIO, CANADA
(Country)		2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Director Restricted Share Units(1)08/11/2026A317 (2) (2)Common Shares317$01,127D
Explanation of Responses:
1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.
2. On August 11, 2026, the reporting person was granted 317 D-RSUs, which vest on May 20, 2027.
/s/ Tracy Connelly McGilley, attorney-in-fact08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR